Shots: Tango to receive $125M up front, $20M as equity investment, up to $410M/ program as an opt-in, extension, and milestones along with royalties on sales of the products. If […]readmore
Tags : Worth
Shots: Denali to receive $560M up front, $465M as equity investment at a price of $34.94/ share, representing 11.2% of Denali’s Pro-forma outstanding stock along with $1.125B as milestones. The […]readmore
Shots: The US government will pay over $1B for 100M doses of its potential COVID-19 vaccine, Ad26.COV2.S, for use in the US following the US FDA’s EUA The government may […]readmore
Shots: Kymera to receive $150M up front, $2B as development, regulatory and commercial milestones along with royalties on sales of therapies. Additionally, the company has an option to develop and […]readmore
Shots: Regeneron and the US Government signed $450M contract for the supply of REGN-COV2 which is currently in two P-II/III clinical trials for the treatment and in a P-III trial […]readmore
Shots: GI Innovations to receive $17M upfront, $1.2B as development & commercialization milestones along with royalties on sales of therapy Yuhan to get global rights (Ex-Japan) to develop and commercialize […]readmore